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The lin-4 RNA acts as a negative regulator of theMichael T. McManus*
developmentally important lin-14 and lin-28 protein-UCSF Diabetes Center
coding genes (Lee et al., 1993; Moss et al., 1997; OlsenDepartment of Microbiology and Immunology
and Ambros, 1999;Wightman et al., 1993). The 22-nucle-University of California, San Francisco
otide lin-4 RNA contains imperfect homology to specificSan Francisco, California 94122
regions of the 3 untranslated regions (UTRs) of lin-14
and lin-28 and, likely, other developmentally important
genes. Genetic data suggested a potential mechanismSmall RNAs of 21–23 nucleotides are powerful regula-
of action: deletion of the lin-4 target sequences in thetors of gene expression and play essential roles in
UTRcauses an unregulatedgain-of-function phenotype.biological processes that include development, main-
In support of this mechanism, reporter genes containingtenance of genome stability, and viral adaptive de-
fusions of the lin-4 UTR renders it susceptible to devel-fense mechanisms. Such small RNAs are simple in
opmental regulation (Lee et al., 1993; Wightman et al.,design yet rich in biology and have captivated the at-
1993). These studies suggested that the lin-4 acts totention of biologists in many fields. This review dis-
downregulate gene expression by binding to the regionscusses the potential roles of small RNAs in immune
of lin-4 homology in the 3UTR. However, it is generallybiology and speculates on their potential participation
not believed that the downregulation is mechanisticallyin lymphogenesis and antiviral mechanisms.
akin to siRNA action. Northern blot analysis of the target
mRNAs indicated that themessage remains stably asso-Introduction
ciated with polysomes, and the current models suggestIn 1998, the Fire and Mello labs described a new tech-
that the action of lin-4 acts via translational repressionnology based on specific gene silencing by double-
(Olsen and Ambros, 1999).stranded RNA, termed RNA interference (RNAi) (Fire et
When lin-4 was originally described, it seemed thatal., 1998). They showed that in C. elegans, the presence
this small RNA was a feature peculiar to worms. Butof just a fewmolecules of double-strandedRNA (dsRNA)
then a second small RNA was found in worms, encodedwas sufficient to essentially abolish the expression of a
by the heterochronic let-7 gene, which was found to begene homologous to the dsRNA. This discovery was
present in other animals (Pasquinelli et al., 2000). Thesoon to illuminate theposttranscriptional gene-silencing
conservation of let-7 gene is striking: it is conservedphenomenon in plants, connecting previous observa-
among bilaterally symmetrical animals, from sea urchintions of silencing activity to mechanisms relating to
to human. Suspecting that even more small RNAs mightdsRNA. Specifically, an important observation in plants
exist among other organisms, three different groups in-suggested that themechanismof dsRNAsilencingmight
dependently developed clevermethods for cloning suchoccur through the action of small 25 nt double-
small RNAs from worms, flies, and mammals. Thesestranded RNAs (Hamilton and Baulcombe, 1999). After
studies surprised the scientific community when it wasthis key observation, studies were initiated to dissect
reported that literally hundreds of different small RNAsthebiochemistry andmolecularmechanismsof theRNAi
exist within cells (Lagos-Quintana et al., 2001; Lau etpathway, using extracts prepared from Drosophila em-
al., 2001; Lee and Ambros, 2001). Because of their smallbryos (Bernstein et al., 2001; Hammond et al., 2000,
size and developmentally temporal manner of expres-2001; Tuschl et al., 1999; Zamore et al., 2000). These
sion, these RNAs were originally named small temporalstudies, which were supported by genetic analysis of
RNAs but are now generally referred to as microRNAs
RNAi in C. elegans (Grishok et al., 2000, 2001; Tabara
or miRNAs (Lagos-Quintana et al., 2001; Lau et al., 2001;
et al., 1999), suggested a two-step model in which 21
Lee and Ambros, 2001).
nt short interfering RNAs (siRNAs) were processed from Many of the microRNA sequences are conserved
long dsRNA and used to specifically degrade mRNA. It throughout evolution, andwenowknow thatRNA silenc-
didn’t take long for the structure of the siRNA to be ing based on microRNAs is ancient in origin and con-
defined, and investigators rapidly embraced RNAi biol- served in plants, animals, and fungi. Each of these or-
ogy by using chemically synthesized siRNAs to perform ganisms produces double-stranded RNA (dsRNA) as
gene function studies in mammalian cells (Elbashir et part of the normal pathways of gene regulation (for re-
al., 2001). While the RNAi pathway was being dissected view, see Baulcombe [2004], Lippman and Martienssen
throughbiochemical andgeneticmeans, it becameclear [2004], Meister and Tuschl [2004], and Mello and Conte
that the pathway served a broad and important role [2004]). The overall mechanisms by which a small RNA
in generating small RNAs to silence endogenous gene may target an mRNA for degradation or translational
expression. The story actually begins almost 15 years repression have been assimilated into a general two-
ago, when Victor Ambros and colleagues discovered step model in which the small RNA is used to direct the
that lin-4, a gene important in the regulationofC. elegans silencing of genes (Figure 1). This review will not cover
developmental timing, did not encode for a protein but the details of small RNA mechanisms of action but in-
instead encoded for a small RNA of approximately 22 stead highlight general aspects of small RNAs that may
nt in length (Lee et al., 1993). relate to immune function. These aspects include the
role of the RNAi pathways in intracellular immunity
against invading nucleic acids (such as transposable*Correspondence: mmcmanus@diabetes.ucsf.edu
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Figure 1. General Model for RNA Interference Pathway
After transcription, microRNAs are processed to yield a 70 nt hairpin RNA by the bidentate RNase III enzyme Drosha. Exportin 5 participates
in the export of the precursor to the cytoplasm, where the bidentate RNase III enzyme Dicer processes the 22 nt microRNA from the stem-
loop precursor. Dicer is at the heart of this pathway and is the veritable engine of small RNA production, catalyzing the cleavage of dsRNA
into siRNAs. The microRNAs and siRNAs can be used to direct translational repression or mRNA degradation, which are believed to be
catalyzed the eif2C family of proteins.
elements and viruses) and the role of the microRNA may be an evolutionary result of the need to swiftly and
simultaneously coregulate several different targets.pathway in cellular differentiation and cancer.
Even though microRNAs were only recently discov- How many microRNAs are there? Several indepen-
dent lines of evidence predict that within the humanered, much has been learned in only a short time (for a
comprehensive review inmicroRNA biology/biogenesis, genome there are approximately 200–255 microRNA
genes; Drosophila, 96–124 microRNA genes; andC. ele-see Bartel [2004], and He and Hannon [2004]). Most
microRNAs are present as solitary elements in the ge- gans, 103–120 microRNA genes (Lim et al., 2003a,
2003b). Thus, it can be estimated that microRNAs maynome, residing in intergenic regions that were previously
thought to be barren of genes and perhaps not even typically constitute approximately 1% of an organisms
known genes. These estimates are based on a combina-transcribed (Lagos-Quintana et al., 2001; Lau et al.,
2001; Lee and Ambros, 2001). However, some can be tion of computational and experimental approaches,
and although a few additional microRNAsmay be found,found in clusters reminiscent of polycistrons, containing
the same or different sequences of microRNAs. In some we suspect that the majority of microRNAs have been
identified in mammalian lineages.cases, the microRNAs may be present within the introns
of protein-encoding genes, perhaps hitchhiking on the Some microRNAs are highly expressed within a given
cell, and others are expressed at levels that are difficulttranscription and regulation of the upstream promoter
of the protein-encoding gene (Lagos-Quintana et al., to detect. For the most highly expressed microRNAs in
C. elegans, the number of transcripts has been esti-2001; Lau et al., 2001; Lee and Ambros, 2001). It may be
speculated that the presence of suchmicroRNAclusters mated to be more than 50,000 molecules per cell—a
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Figure 2. MicroRNAs Are Transcribed as Spliced RNAs and Are Encoded within Introns and Exons
This schematic depicts a sampling of microRNA primary transcripts (pri-cursors). (A) The splicing of the chromosome 1 miR-181/213 locus
is complicated and not defined. Sequencing data generated from LPS activated chicken cell lines suggests that in some ests, an alternative
splice site interrupts the miR-213 microRNA. On human chromosome 1, the miR-181/213 pri-cursor is transcribed approximately 100 kb
downstream and in the opposite orientation of the CD45 gene. (B) The miR-198 gene appears to be expressed within the UTR of an
uncharacterized gene related to the follistatin-like gene family, which is thought to be an autoantigen associated with rheumatoid arthritis
that may modulate the action of some growth factors on cell proliferation and differentiation. (C) miR-7-1 is expressed in a position that is
conserved in both insects and mammals: in the second intron of the heteronuclear ribonuclear protein K (Aravin et al., 2003). (D) miR-21 is
encoded in a nonspliced transcript. The above splicing schematics are not drawn to scale, and additional exons and introns may not be
depicted in the figure.
greater abundance than that of the U6 snRNA of the 2) (Cai et al., 2004; Lee et al., 2004). In support of this,
many microRNA primary transcripts can be found in estspliceosome (Lim et al., 2003b). Other microRNAs ap-
pear to be expressed at levels that are barely detectable libraries and can be quite long (3 kb or longer). In addi-
tion, the microRNA promoter can be used to expressby Northern blot analysis. However, when estimating
the expression level of a given microRNA from a given protein-encoding reporter genes, and there is at least
one documented case in which a Myc gene was ex-tissue, it is important to realize that the microRNA may
be expressed in only a small subset of cells within a pressed from a microRNA promoter in an aggressive B
cell leukemia (Gauwerky et al., 1989). These data aregiven tissue. Thus, it may be prudent to use methodolo-
gies that may probe the expression patterns of micro- important, because they suggest that the regulation of
microRNA expression may be as rich and as compli-RNAs within a given tissue, such as the use of micro-
RNA microarrays on selected cell types (Calin et al., cated as protein-encoding genes, sharing many of the
same transcription factors. In fact, it seems that some2004a; Esau et al., 2004; Miska et al., 2004) or in situ
approaches similar to what has been recently reported alternative splicing of microRNAs may occur, hinting at
a possible way to regulatemicroRNAexpression. I foundfor use in the mouse (Mansfield et al., 2004).
Little is known about the regulation of microRNA ex- one example in the miR-181b-1/213 cluster, where the
5 half of miR-213 precursor (encoding miR-181a) canpression, but the emerging evidence suggests that
most, if not all, microRNAs are transcribed by polymer- be alternatively spliced in the predicted pre-microRNA
stem loop (Figure 2A).ase II (Cai et al., 2004; Lee et al., 2004). Although poly-
merase II is the enzyme generally known to transcribe How do microRNAs work? Current data argue that
microRNAs can exhibit their silencing effects by twoprotein-coding genes, it is not unusual that it transcribes
noncoding RNAs. In fact, polymerase II transcribes separate mechanisms: translational repression and
mRNA degradation. The mechanisms for how the trans-some noncoding RNAs, including the small nucleolar
RNAs and four of the small nuclear RNAs of the spliceo- lational repression occurs are not understood, but the
interaction is characterized by (1) imperfect pairing be-some. Like other polymerase II transcripts, the primary
microRNA transcripts (pri-miRNAs) contain cap struc- tween the microRNA and the target and (2) a correspon-
dence between the degree of repression and the numbertures, undergo splicing, and contain poly(A) tails (Figure
Immunity
750
Figure 3. Dichotomy of Small RNA Interactions with mRNAs
(A) A short stretch of the C. elegans lin-41 UTR is shown base paired to the let-7 microRNAs. This interaction is characterized by multiple
target binding sites and imperfect hybridization.
(B) A short stretch of the HoxB8 UTR is shown base paired to the miR-196 microRNA. Only one target site is present, and the interaction is
perfectly complimentary, save for one G:U wobble base pair.
of target sites. This is illustrated by the interaction of where read-through transcription could result in the pro-
duction of dsRNA sequence (Plasterk, 2002). The higherlet-7 with the lin-41 untranslated region (Reinhart et al.,
the copy number of the element, the greater the chance2000) (Figure 3A). ThosemicroRNAs that promotemRNA
of read-through transcription from flanking promoter ac-degradation do so by acting as siRNAs. Here, only one
tivity and of the element will becoming subject to RNAi.interaction of perfect/near-perfect hybridization is needed
Additional data in plants, fungi, and mammals indicatesto suppress the expression because themicroRNAguides
that dsRNA and siRNAs have the capacity to direct het-the cleavage of the mRNA, which occurs between the
erochromatin formation and methylation (Kawasaki andtenth and eleventh nucleotide, starting from the small
Taira, 2004; Lippman and Martienssen, 2004, Morris etRNA 5 end. In plants, this second mechanism is princi-
al., 2004). Thus, the mechanisms for transposon silenc-pally how microRNAs act (Rhoades et al., 2002); how-
ing may additionally be at the transcriptional level.ever, in animals, only one microRNA so far has been
Whichever the mechanism, it seems that the RNAi path-shown to act as a siRNA. This is the microRNA termed
way may have played a critical role in the sculpting ofmiR-196, which appears to target the HoxB8 mRNA for
the entire genome, limiting mobile elements to a limiteddegradation (Figure 3B) (Mansfield et al., 2004; Yekta et
number of transpositions. It is not known whether mam-al., 2004). At present, it is unknownwhether other animal
mals employ the RNAi pathway to achieve immunitymicroRNAsmay act by targeteddegradation of themRNA.
against such “invaders from within,” but the large num-
ber of mammalian homologs to the C. elegans genes
RNAi and Immunity required for this process suggests conservation in
Immunity Against Invasive Nucleic Acids mechanisms for intracellular immunity (Vastenhouw et
Fungi, plants, invertebrates, and vertebrates enlist a al., 2003).
remarkable array of gene-silencing systems to combat Immunity Against Viruses
the harmful effects of invasive nucleic acids. Forty-five A second intersection between the RNAi pathway and
percent of the human genome sequence volume con- immune function is present in plants and perhaps in-
sists of remnants of previous transposon/virus invasion, sects where the RNAi pathway is an essential means of
including a few elements that are still active and may immunity against viruses (for review, see Baulcombe
cause human disease (McPherson et al., 2001). In princi- [2004]). Although plants do not possess the antibody-
ple, the genome faces the same set of challenges that based immune response that animals have evolved, the
the vertebrate immune system faces: how to distinguish basic tenants of adaptive immunity are retained, and a
self from nonself and how to mount and amplify an comparison can be drawn between the antibody-centric
immune response against invading elements in a spe- immune response and the RNAi immune response (Fig-
cific manner. ure 4).
Accumulating data indicates that small RNAs are cen- In this model and during the recognition stage, Dicer
tral ammunitions in a host defense response against locates and recognizes viral dsRNA. This must be ac-
such invasive nucleic acids. In worms, defects in certain complished in a way to distinguish self from nonself,
RNAi pathway genes result in the activation of multiple because it is possible that some dsRNA might be ex-
transposable elements in the germline, indicating that pressed within cells. In a manner somewhat similar to
RNAactively represses the spread of transposonswithin antigenprocessing,Dicer cleaves the longer viral dsRNA
the genome (for a recent review, see Vastenhouw and into short pieces of dsRNA called small interfering RNAs
Plasterk [2004]). How might the RNAi pathway achieve (siRNAs). In the “clonal expansion” phase, the siRNAs
this role? Work performed by the Plasterk group has are amplified with the aid of an RNA-dependent RNA
shown that the transposons regulated by RNAi genes polymerase (RdRP), which may use the siRNA strands
and perhaps bits of single-stranded viral RNAas primersin C. elegans have terminal inverted repeat structures,
Review
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Figure 4. Basic Phases of the Cellular Immune Response to dsRNA via the RNAi Pathway
In this model, which is somewhat analogous to the antibody immune response in animals, the basic tenants of adaptive immunity are retained:
antigen recognition, activation, elimination of antigen, decline, and memory. For details, see text.
to create more viral dsRNA, which is quickly processed mRNAs. During the process of viral clearance in the
plant, there is turnover of the RiSC and Dicer complexesby Dicer. Alternatively, the action of Dicer along a long
stretch of dsRNA may generate a diverse number of and a gradual decline of viral siRNAs; however, memory
of the infection is possible, because remaining circulat-different siRNA sequences. In this way, large numbers
of siRNAs can be generated from small amounts of viral ing siRNAs can render the plant resistant to further infec-
tion by the same virus or viruses related by sequencedsRNA. Presumably, clonality of the siRNA population
might be achieved through multiple cycles of this pro- homology (for review, see Baulcombe [2004]).
Thus, viruses are both inducers and targets of thecess, and selection of highly efficient siRNA sequences
may be dependent on the ability of the siRNA to associ- RNAi pathway, and as one would expect, they have
evolved clever strategies to counteract the RNAi-basedate with and be used in directing silencing (Khvorova et
al., 2003). In plants, “activation” is achieved during this defense mechanism. Viral genomes encode efficient
suppressors of the RNAi pathway. The diversity of sup-reiterative process of siRNA amplification; however, no
RdRP gene has yet been described in mammals. Like pressor sequences suggests that these proteins have
evolved independently. For most plant suppressors ofantibodies that have access to the circulatory system,
the siRNAs can be transported through the vasculature silencing, the mechanisms of RNAi inhibition remain un-
clear. However, molecular and biochemical data com-of plants, in essence rendering a systemic immune re-
sponse to the initial viral infection (Yoo et al., 2004). The bined with a crystal structure of one viral suppressor
suggests one mechanism of RNAi inhibition (Vargasoneffector phase, which represents the stage in which
antigens are eliminated, is initiated when one of the et al., 2003; Ye et al., 2003). The p19 (encoded by the
tomato bushy stunt virus) andp21 (encodedby thewest-siRNA strands is presented to the downstream RNAi
Silencing Complex (RiSC). When this complex is charged ern beet yellow virus) suppressors act by binding to the
siRNAs and preventing their association with RiSC. Itwith a siRNA strand, it becomes competent for per-
forming cleavage and removal of single-stranded viral seems the sheer act of sequestering, or “sopping up,”
Immunity
752
the siRNAs is sufficient to allow the virus to successfully investigate these ideas, since drugs designed to target
viral suppressors might be effective therapeutics, be-infect the cell.
Although the parallels to RNAi in plants and adaptive cause theywould give the cell a better chance to destroy
virus by RNA interference.immunity in mammals are clear, it should be made clear
that there are shortcomings in this model for RNAi in There are additional data to suggest another role for
the RNAi pathway in viral biology. A recent report indi-mammals. For instance, there is no evidence for the
RNA amplification step (via RdRP activity). There is also cates that viruses may have adopted the RNAi pathway
as a convenient method for regulation of host and viralno evidence for any systemic spread in mammals. Per-
haps these functions were lost in evolution; it is very gene expression in a nonimmunogenicmanner. It is per-
haps not surprising to find microRNAs in viral genomes,clear that mammals have found alternative pathways to
RNA for the clearance of virus. Onewell-known example given that viruses are experts at usurping cellular mech-
anisms for the regulation of gene expression for theirof this relates the dsRNA interferon response, in which
the presence of long dsRNA in the cytoplasm of cells own gain. Five different microRNAs have been identified
in the genome of the Epstein-Barr virus (EBV) (Pfeffertriggers the production of type I interferon (IFN-/) (re-
viewed inKumar andCarmichael [1998]). This is a central et al., 2004). EBV is a large DNA virus of the herpes
family that preferentially infects human B cells. Theseevent in the mammalian antiviral immune responses and,
in conjunction withmultiple signals, can stimulate apopto- microRNAs are predicted to target a variety of genes,
including regulators of cell proliferation and apoptosis, Bsis and inhibition of translation. It is unknown whether
the dsRNA interferon response and related pathways cell-specific chemokines and cytokines, transcriptional
regulators, and components of signal transduction path-collaborate with RNAi to achieve viral clearance.
Given the evolutionary conservation of the RNAi path- ways (Pfeffer et al., 2004). In fact, at least one of the
microRNAs may target a gene encoded in the viral ge-way among plants and animals, it would not be alto-
gether surprising to find that similar antiviral cellular nome itself. It remains to be shown whether these mi-
croRNA-target interactions are significant for the regula-immunity pathways exist in animals as in plants. If so,
one would expect that animal viruses might also have tion of viral infection or replication; if they are critical,
novel therapeutics may be developed that moderate theevolved means to counter an RNA interference antiviral
pathway, and there are a limited number of preliminary microRNA-mediated effects.
MicroRNAs in Immune Cancersreports to support this idea. The Influenza NS1 and Vac-
cinia E3L proteins and the Flockhouse B2 protein have Because microRNAs have been shown to participate as
regulators in differentiation and proliferation pathways,been reported to contain silencing suppressor activity
(Li et al., 2002; Vargason et al., 2003; Ye et al., 2003). it is likely that they will participate in human diseases
such as cancer. A number of different studies are provid-However, their mechanisms of action are unclear, and
the current data might simply reflect a side effect of ing support for this idea. In fact, microRNA participation
in human disease was suggested before microRNAstheir ability to bind to dsRNA (although remember that
the p19 suppressor operates in exactly this way). The were even classified. That is, almost six years ago Tam
et al. reported on a novel noncoding RNA gene that wasInfluenza NS1 and Vaccinia E3L protein studies were
also indirect in that the suppressors were tested in het- activated by proviral insertions in avian leukosis virus-
induced B cell lymphomas (Clurman and Hayward,erologous systems rather than the natural context: the
mammalian suppressors NS1 and E3L were each tested 1989). It is only now that we understand that this proviral
insertion is upstream of and drives expression of miR-for anti-RNAi activity in insect cells (Li et al., 2004). Al-
though the Flockhouse virus may replicate in mamma- 155. The bic gene (which contains the miR-155 primary
microRNA precursor) consists of two exons and is ex-lian cells, it is naturally a plant/insect RNAi suppressor
and, thus, was not characterized in mammalian cells. pressed as two spliced and alternatively polyadenylated
transcripts at low levels in lymphoid/hematopoietic tis-Taken together, the above studies suggest a potential
conservation in the RNAi-based antiviral response in sues. The frequent association with c-myc activation
and preferential activation in metastatic tumors sug-plant and animal kingdoms.
A recent study shows that a mammalian viral gene gests that the Bic locus harbors a gene that can collabo-
rate with c-myc in lymphomagenesis and play a role inproduct may inhibit RNAi in mammalian cells and, more
potently, inhibit the expression of microRNAs (Lu and late stages of tumor progression (Tam et al., 1997).
Because the original reports of proviral insertions intoCullen, 2004). This inhibition is at least partly due to
competition with the small RNA nuclear export factor, the Bic locus, the Bic RNA has also been identified as
an RNA that is differentially expressed genes duringExportin 5, and perhaps to competition with Dicer activ-
ity. This gene product is the adenovirus noncoding RNA T cell activation (Haasch et al., 2002). In this study, librar-
ieswere prepared from normal humanCD4 est librariesVA1, a highly structured 160 nt RNA that has a described
role in blocking PKR activity during viral infection (Ma- stimulated with CD3 mAb (to mimic TCR engagement)
or CD28 mAb (costimulatory signal) or both (CD3 andthews and Shenk, 1991). In fact, all of the described
mammalian RNAi inhibitors are well-documented inter- CD28mAbs) and analyzed for ests that exhibited signifi-
cant differences of expression. T cell lymphocytes fullyferon agonists, and, thus, the question regarding RNAi
in mammalian innate immunity seems convoluted. No activatedby simultaneous treatmentwithCD3 andCD28
mAb showed a 35- to 40-fold increase in Bic RNA tran-lab has demonstrated that viruses with deletions of the
presumed RNAi inhibitor genes can be rescued by inhi- scription. The bic gene was identified in this screen and
it was determined that the Bic RNA is present withinbition of RNAi as has been done in the interferon system.
Given the importance of the topic, a call for more defini- brain, lung, testis, and thymus. Additional ests were
found in libraries generated from synovial fluid from ar-tive experiments is in order. It will be important to further
Review
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Figure 5. MicroRNAs as Participators in Oncogenic Pathways
Similar to polymerase II-mediated transcription of protein-encoding genes, transcription of microRNAs may be regulated by external stimuli,
such as cytokines, hormone ligands, cell contact, etc. The microRNA produced from the nascent transcript may participate in pathways
involved in diseases such as cancer. In this speculative model, the microRNA may modulate the expression of tumor suppressors, oncogenes,
and/or transcription factors, leading to a change in differentiation, proliferation, and apoptosis. Cancer might ensue as a direct consequence
of mutation in the microRNA or microRNA binding site within the UTR of a gene or perhaps as a result of defects in the regulation of expression
of the microRNA. Alternatively, such defects may assist oncogenesis in a collaborative role, such as suggested by the collaboration of miR-
155 with myc (Tam et al., 2002) (figure adapted from McManus [2003]).
thritic joints, colon from ulcerative colitis patients, and It is likely that noncoding RNAs will be important col-
laborators in disease aswe struggle to define what func-lymphoma. The authors demonstrated that the expres-
sion of the bic gene is sensitive to the inhibition by the tions microRNAs perform. The Croce lab has reported
that miR-15a and miR-16a, located at 13q14, are fre-immunosuppressive drugsCsa, FK506, anddexametha-
sone, which are known to affect the inactivation of tran- quently deleted and/or downregulated in patients with
B cell chronic lymphocytic leukemia (B-CLLs), the mostscription factors such as NFAT, or AP-1 and NF-B that
control the T cell activation genes such as cytokines. common form of adult leukemia in the Western world
(Calin et al., 2002; Dohner et al., 2000). Deletions atAlthough it was suggested that the Bic RNA might be
selectively expressed in immune cells involving inflam- this region occur in approximately 50% of mantle cell
lymphoma, in 16%–40% of multiple myeloma, and inmatory or autoimmune responses, the function of Bic
or the miR-155 encoded within the Bic transcript is not 60% of prostate cancers, suggesting that one or more
tumor suppressor genes may be present in this locusunderstood. Thus far, studies of Bic suggest a role in
T cell activation and perhaps oncogenesis, a definitive (Dong et al., 2001). The microRNAs miR-15 and miR-16
appear to be deleted in the majority of CLL cases. Ifconclusion will await the ablation and characterization
of this gene in the mouse. the loss of the 13q14 miR-15/16 locus is integral in the
pathology of CLL, then the data byCalin et al. are consis-The bic gene is not the only previously identified bio-
logically relevant noncoding RNA that harbors a mi- tent with the idea that a miRNA might act as a tumor
suppressor (Figure 5) (McManus, 2003).croRNA. Translocation of Myc into the miR-142 loci
causes an aggressive B cell leukemia because of strong In an effort to determine whether the above observa-
tions may extend to other microRNAs, the Croce groupupregulation of Myc expression (Gauwerky et al., 1989).
Although it was not known at the time that a microRNA has compared the genomic location of 186 microRNA
genes to previously reported nonrandom genetic alter-was present in this location, alignment of mouse and
human miR-142 containing EST sequences reveals that ations (Calin et al., 2004b). Their data argues that mi-
croRNAs are frequently located at fragile sites as wella 20 nt conserved sequence element exists down-
stream of themiR-142 hairpin, which is lost in the trans- as in minimal regions of loss of homozygousity, minimal
amplicons, or common breakpoints. Their estimates in-location (Lagos-Quintana et al., 2002). The Myc gene
translocated only four nucleotides downstream of the dicate that approximately 52% (98 of 186) of microRNA
genes are in such fragile sites. Although the accumulat-miR-142 3 end and is likely under control of the up-
stream microRNA promoter. Currently, it is unknown ing data are seductive, it is still not clear whether micro-
RNAs are the culprits in directing the cell down an onco-how and, indeed, whether miR-142 is a critical factor in
the pathogenesis of leukemia. genic pathway. Conceivably, the correlation between
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fragile sites and microRNAs might be a downstream in the RNA interference phenomenon is a tribute to the
event, and that deletion of the microRNAs may simply biological potency of small RNAs, the breadth of small
reflect the efforts of the cell to adjust to their newcancer- RNA intersection into many fields, and the sheer novelty
ous identity or environment. A more complete analysis of small RNA actions. Perhaps it is too early to speculate
awaits the study of microRNA misexpression and/or on the range of ways that microRNAs and RNAi might
knockout mouse models for cancer. relate to fundamental biology in immune cells. However,
How might microRNAs participate in cancers? Pre- the accumulating data are exciting and it may be only
sumably they repress normal translation by binding to a matter of time before we can fully appreciate the de-
the mRNA of developmentally important genes. Consid- gree to which the RNAi pathway participates in regulat-
ering sequence complimentarity of microRNAs to the ing immune cell function.
3UTR, it has been suggested that at least some micro-
AcknowledgmentsRNAs may bind to the 3UTRs of Notch pathway target
genes encoding basic-helix-loop-helix (bHLH) repres-
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